NBP
NovaBridge Biosciences
1.40$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -410.3% | – | +6,207.8% | -100.0% | – | – | – | – | -100.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -410.3% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -79.7% | -14.1% | +181.0% | -95.9% | +34.7% | -87.1% | +323.9% | -3.6% | +1,652.5% | -87.1% | -0.3% | – | |
| – | -15.1% | -50.3% | +67.9% | -90.8% | -7.5% | -38.9% | -14.9% | +52.2% | +196.6% | -23.5% | -0.3% | – | |
| – | -56.8% | -39.3% | +116.5% | -93.7% | +7.7% | -60.6% | +35.1% | +26.4% | +711.0% | -72.1% | -0.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -258.5% | – | – | – | – | – | – | – | – | – | |
| – | -153.6% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.